Trade Aligos Therapeutics, Inc. - ALGS CFD

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a synthetic oligonucleotide that is in Phase I clinical trial for the treatment of chronic hepatitis B (CHB); and ALG-000184, a capsid assembly modulator, which is in Phase I clinical trials to treat CHB. The company is also developing ALG-020572, an antisense oligonucleotide to decrease HBsAg levels; and ALG-055009, a small molecule THR-ß agonist for the treatment of non-alcoholic steatohepatitis. In addition, it is developing siRNA drug candidate, ALG-125755, as well as ALG-125097 and ALG-125819, demonstrated potent inhibition of HBsAg release from HBV-infected cells. The company has entered into license and collaboration agreements with Luxna Biotech Co., Ltd. to develop and commercialize products containing oligonucleotides targeting SARS-CoV-2; and research, licensing, and commercialization agreement with Katholieke Universiteit Leuven to develop coronavirus protease inhibitors. It has research partnership with Vipergen ApS to develop DNA Encoded Library (DEL)-based drug discovery for viral infections and liver diseases. Aligos Therapeutics, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.

Latest shares articles

BYD stock forecast: Will Chinese EV maker recover? YD Auto Signage Logo on Top of Glass Building. Workplace Car Company Office Headquarter.
BYD stock forecast: Third-party price target
Discover third-party BYD (1211) price predictions for 2025 and beyond, with analyst targets, price history, and trading strategies.
11:40, 10 April 2025
Aston Martin car front logo
Aston Martin forecast: Third-party price target
Discover third-party Aston Martin price predictions for 2025-2030 and beyond, with analyst targets, historical prices, and trading strategies.
10:05, 10 April 2025
Volkswagen logo on a smartphone screen
Volkswagen forecast 2025-2030: Third-party price target
VW stock has been on a downtrend lately. Can this stock make a comeback this year?
15:56, 9 April 2025
Tesla’s logo on a building
Tesla (TSLA) stock forecast: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
09:23, 9 April 2025

Read our reviews to find out more about us1

Read the feedback from our clients, whatever their experience level.
2024-10-22
i*******

Very trustworthy and affordable for any size trades

2024-10-21
r*****

It is very easy to connect with TradingView but the web interface is also great.

2024-10-15
j********

Easy to use and great support. Been using it for 2 years already and still happy

2024-10-14
D*****

Capital.com is one of the best stock trading platforms I’ve used. The UX and UI on both the mobile app and web platform are outstanding, making it incredibly easy to navigate. They’ve built a vibrant community of traders and investors, and their UAE team really stands out for delivering an exceptional trading experience.

2024-10-08
Y**********

Best broker!! they call you to see if you need any help. The app is good and nice better than the rest

2024-10-04
I**** S*******

Great app! I requested some features to be added, such as analysis tools, and they delivered. Amazing job! The agents are always helpful and reply quickly. It’s not 5 stars because, at times, some less experienced agents may say it’s impossible to fulfill the request or fix the problem while another agent, like Angel, quickly escalated the issue to the necessary team/person/department and resolved it

2024-10-04
M** S*

This is an excellent platform. The stop loss and take profit work very well; however, when the changes are very fast like at the beginning of the session, the stop loss does not work. If this defect is corrected it will be the perfect platform.

2024-09-30
a************

-Nice -Easy to use - Beautiful Interface

2024-09-26
D*****

I think I'm new in this trading platform, but I find it affordable and most reliable. To be honest I'm not fully experienced trader, but with very limited knowledge of trading I try learn as much as I can by trying out different platforms see if can make money. My interests growing in you platform, l like news updates you also short videos on YouTube, other propaganda, poster and many more. I will see what happens in the coming months. Thanks capital team.

2024-09-26
J*** F******

Gives you options to start learning how too do it as it gives you a demo option to learn from your mistakes

2024-09-24
P******

Efficiency. When creating the account, it was smooth, efficient from start to finish. Verification of documents also was done the same day, unlike other platforms where you have to wait a day or two.

2024-09-04
O****** P***

From what I'm seeing it's cool Mixing it with trading view it's perfect... I didn't give it 5 star yet cos I still need to use it for some time

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

Join our community of traders worldwide
1. Create your account2. Make your first deposit3. Start trading